Safety and Efficacy of Ataluren (PTC124) for Cystic Fibrosis

Clinical trial NCT00237380 · COMPLETED

Trial details

NCT number: NCT00237380
Sponsor: PTC Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2005-11-30
Primary completion: 2006-05-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.